SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001622627-24-000022
Filing Date
2024-04-25
Accepted
2024-04-25 18:52:39
Documents
2
Group Members
GIL AHARONROSALIND ADVISORS, INC.ROSALIND MASTER FUND L.P.SALAMON STEVEN A J

Document Format Files

Seq Description Document Type Size
1 rosalind_sprb_13ga01_apr25.htm SC 13G/A 88676
2 ex_a_sprb_13g_04-02-2024.htm EX-99.A BD-DIR-RESOL 2444
  Complete submission text file 0001622627-24-000022.txt   92847
Mailing Address 15 WELLESLEY STREET WEST SUITE 326 TORONTO A6 M4Y 0G7
Business Address 25 ADMIRAL ROAD TORONTO A6 M5R 2L4 4168887606
Rosalind Advisors, Inc. (Filed by) CIK: 0001622627 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1130
Type: SC 13G/A

Mailing Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080 (415) 655-4168
SPRUCE BIOSCIENCES, INC. (Subject) CIK: 0001683553 (see all company filings)

IRS No.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91764 | Film No.: 24878027
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)